Global Liquid Biopsy Market research report published by Stratview Research studies the latest Liquid Biopsy industry aspects like market size, trends, opportunities, and strategies to boost growth, revenue, marketplace expanding, technological innovations and more. The report covers the data from 2022-2028 for the sector. The report also provides a comprehensive overview of demand supply and key participants can consider the statistics, tables and figures mentioned in this report for strategic planning which will lead to the success of the organization.
The recent report on the Liquid Biopsy Market published by Stratview Research is segmented By Products Services Type (Assay Kits, Instruments, and Services), by Application Type (Cancer {Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, and Others} and Non-Cancer), by Clinical Application Type (Therapy Selection, Treatment Monitoring, Recurrence Monitoring, and Early Cancer Screening), by Circulating Biomarkers Type (Circulating Tumor Cells, Cell-Free DNA, Circulating Tumor DNA, Extracellular Vesicles, and Others), by Technology Type (Multi-Gene Parallel Analysis Using NGS and Single-Gene Analysis Using PCR Microarrays), by End-User Type (Reference Laboratories, Hospitals and Physician Laboratories, Academic Research Centers, and Others), and by Region.
It also covers the COVID-19 Impact Analysis and Forecast to 2028. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global liquid biopsy market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2028.
Impact of COVID-19 on Liquid Biopsy Market
With COVID-19, the world is battling a health pandemic as well as an economic pandemic, virtually affecting trillions of dollars of incomes. Stratview Research brings to you high level insights and in-depth details related to rapid modifications in top companies in each sector, growth and decline due to COVID-19, etc. The analysts at Stratview Research are constantly engaging with their clients and other key players of almost all the industries, regarding the impact of COVID-19 on their businesses.
Market Insights
The liquid biopsy market size was valued at US$ 2.4 billion in 2021 and is expected to grow at a CAGR of 18% during 2022-2028 to reach US$ 7.64 billion in 2028.
Key players
Some of the major players operating in the global liquid biopsy market are-
Biocept Inc.
Bio-Rad Laboratories
- Hoffmann-La Roche Ltd.
Guardant Health Inc.
Illumina, Inc.
Johnson Johnson
Laboratory Corporation of America Holdings
MDxHealth SA
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Market Drivers
The growth of the liquid biopsy market is primarily driven by:
Increase in the number of cancer patients,
Increasing demand for non-invasive treatment procedures,
Growing awareness about the benefits of liquid biopsy,
Advantages such as low cost, rapid and accurate results, and early detection of diseases.
Regional Trends
Among these regions, Asia-Pacific is expected to be the fastest-growing region in the market during the forecast period.
In 2021, North America had the highest revenue share of over 50%. Due to higher investments and the existence of numerous biotechnology businesses developing the tests in the U.S., this region dominates the most.
The market is segmented as North America, Europe, Asia-Pacific, and Rest of the world. The region is distinguished by rising disposable income, increasing healthcare expenditure, growing awareness of liquid biopsy techniques, and rising adoption of advanced diagnostic techniques in hospitals, clinics, and diagnostic laboratories. The growing penetration of hospitals and diagnostic centers in the region is likely to bolster the growth of the market over the forecast period. North America and Europe are also expected to offer substantial growth opportunities during the forecast period.
Critical Questions Answered in the Report
What are the key trends in the global liquid biopsy market?
How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in next five years?
What is the impact of COVID-19 on global liquid biopsy market?
What are the key strategies adopted by the major vendors to lead in the global liquid biopsy market?
What is the market share of the top vendors?
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.
